Lentiviral-mediated Smad4 RNAi promotes SMMC-7721 cell migration by regulation of MMP-2, VEGF and MAPK signaling

Molecular Medicine Reports

Volumn 3, Issue 2, 2010, Pages 295-299

  Huang, Xiaodan ^a   Huang, Shu ^a   Zhang, Faming ^a   Han, Xiang ^a   Miao, Lin ^a   Liu, Zheng ^a   Fan, Zhining ^a   Ji, Guozhong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Erk1 2; Hepatocellular carcinoma; JNK; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Metastasis; P38; Smad4; Transforming growth factor ; Vascular endothelial growth factor

Indexed keywords

GELATINASE A; GELATINASE B; LENTIVIRUS VECTOR; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD4 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 77950806797     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_000000254     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, ChenCS, Chen J, Wildman RP, Klag MJ and Whelton PK: Major causes of death among men and women in China. N Engl J Med 353: 1124-1134, 2005.
3. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243: 229-235, 2006.
4. Liu J, Du W and Fan D: Survivin, the promising target in hepatocellular carcinoma gene therapy. Cancer Biol Ther 7: 555-556, 2008.
5. Bierie B and Moses HL: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520, 2006.
6. Pardali K and Moustakas A: Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775: 21-62, 2007.
7. Massague J: TGFbeta in Cancer. Cell 134: 215-230, 2008.
8. Oft M, Heider KH and Beug H: TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8: 1243-1252, 1998.
9. Bierie B and Moses HL: TGF-beta and cancer. Cytokine Growth Factor Rev 17: 29-40, 2006.
10. Padua D and Massague J: Roles of TGFbeta in metastasis. Cell Res 19: 89-102, 2009.
11. Derynck R, Zhang Y and Feng XH: Smads: transcriptional activators of TGF-beta responses. Cell 95: 737-740, 1998.
12. Yamaguchi H, Shimizu M, Ban S, et al: Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 33: 1164-1172, 2009.
13. Deng H, Ravikumar TS and Yang WL: Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett 281: 220-231, 2009.
14. Garamszegi N, Garamszegi SP, Shehadeh LA and Scully SP: Extracellular matrix-induced gene expression in human breast cancer cells. Mol Cancer Res 7: 319-329, 2009.
15. Ji G, Wang X, Miao L, Liu Z, Zhang P, Zhang F and Yang J: Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma. World J Gastroenterol 12: 644-648, 2006.
16. Huang S, Zhang F, Miao L, Zhang H, Fan Z, Wang X and Ji G: Lentiviral-mediated Smad4 RNA i induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Oncol Rep 20: 1053-1059, 2008.
17. Jazag A, Ijichi H, Kanai F, et al: Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Oncogene 24: 662-671, 2005.
18. Ji G, Zhang F, Zhai H, Fan Z, Fan D and Wang X: Construction and identification of lentiviral vector of RNA interference of Smad4 gene. J Fourth Mil Med Univ 27: 600-602, 2006.
19. Zhang F, Ren G, Lu Y, et al: Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker. Cancer Lett 274: 250-258, 2009.
20. Xu X, Kobayashi S, Qiao W, et al: Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest 116: 1843-1852, 2006.
21. Herzer K, Grosse-Wilde A, Krammer PH, Galle PR and Kanzler S: Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1. Mol Cancer Res 6: 1169-1177, 2008.
22. Lunt SJ, Chaudary N and Hill RP: The tumor microenvironment and metastatic disease. Clin Exp Metastasis 26: 19-34, 2009.
23. Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172, 2009.
24. Rydlova M, Holubec L Jr, Ludvikova M Jr, Kalfert D, Franekova J, Povysil C and Ludvikova M: Biological activity and clinical implications of the matrix metalloproteinases. Anticancer Res 28: 1389-1397, 2008.
25. Oshima T, Kunisaki C, Yoshihara K, et al: Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer. Oncol Rep 19: 1285-1291, 2008.
26. Taras D, Blanc JF, Rullier A, Dugot-Senant N, Laurendeau I, Vidaud M and Rosenbaum J: Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity. J Hepatol 46: 69-76, 2007.
27. Hirakawa S, Hong YK, Harvey N, Schacht V, Matsuda K, Libermann T and Detmar M: Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 162: 575-586, 2003.
28. Qu Z, van Ginkel S, Roy AM, Westbrook L, Nasrin M, Maxuitenko Y, Frost AR , Carey D, Wang W, Li R, Grizzle WE, Thottassery JV and Kern FG: Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors. Cancer Res 68: 6232-6240, 2008.
29. Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI and Kirkpatrick CJ: Hypoxia-induced epithelial VEGF-C/VEGFR-3 up-regulation in carcinoma cell lines. Int J Oncol 32: 585-592, 2008.
30. Yang Y, Zhou F, Fang Z, Wang L, Li Z, Sun L, Wang C, Yao W, Cai X, Jin J and Zha X: Post-transcriptional and post-translational regulation of PTEN by transforming growth factor-beta1. J Cell Biochem 106: 1102-1112, 2009.
31. Deng J, Qian Y, Geng L, Chen J, Wang X, Xie H, Yan S, Jiang G, Zhou L and Zheng S: Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2). Liver Int 28: 1458-1464, 2008.
32. McKillop IH, Schmidt CM, Cahill PA and Sitzmann JV: Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. Hepatology 26: 1484-1491, 1997.
33. Klein PJ, Schmidt CM, Wiesenauer CA , Choi JN, Gage EA , Yip-Schneider MT, Wiebke EA , Wang Y, Omer C and Sebolt-Leopold JS: The effects of a novel MEK inhibitor PD184161 on MEK-ER K signaling and growth in human liver cancer. Neoplasia 8: 1-8, 2006.
34. Huynh H, Soo KC, Chow PK and Tran E: Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma. Mol Cancer Ther 6: 138-146, 2007.